NGcGM3/VSSP/Montanide ISA 51 vaccine for breast cancer IIa, IIb and IIIa surgically treated with positive ganglia and disease-free, Phase IIb/III. |
2010-12-17 |
CIM |
Nimotuzumab in tumors of head and neck .Phase IV |
2013-02-01 |
CIMAB |
Nimotuzumab-pancreatic cancer-adults-Phase IV. |
30/04/2017 |
CIM |
Pharmacokinetics of the Intralesional administration of rhEGF (doses: 75 µg and 225 µg) in advance Diabetic Foot Ulcers |
2013-02-08 |
CIGB |
Phase I/II clinical trial for the evaluation of vaccine candidate CIGB-230 in patients with chronic renal insufficiency. |
2010-09-27 |
CIGB |
Phase II / III. Nimotuzumab in patients with triple-negative breast cancer. |
23/05/2014 |
CIM |
Phase II clinical trial for the evaluation of the therapeutic vaccine candidate Terap C. |
2009-02-11 |
CIGB |
PLASMA TREATMENT TO ASYMPTOMATIC PATIENT WITH COVID-19 INFECTION |
03/07/2020 |
IHI |
Pneumococcal conjugate vaccination among Warao children |
2013-06-14 |
SAIB |
Predictor of response with CIMAvax EGF© in NSCLC Phase III |
29/01/2016 |
CIM |
PrevengHo-Vir Homeoprohylaxis COVID-2019 |
13/05/2020 |
MINSAP_MNT |
Racotumomab,Nimotuzumab or Docetaxel in the treatment of the advanced non-small cell lung cancer. |
26/05/2014 |
CIM |
RituxCIM in relapsed or refractory indolent B-cell non-Hodgkin lymphoma |
05/11/2013 |
CIM |
rTMS-stroke-phase I |
2009-05-29 |
CIREN |
Safety and effectiveness of SURFACEN® combined with the conventional therapy, in the treatment of ARDS in pediatrics. National extension |
29/09/2017 |
CENSA |
SOBERANA 01 |
13/08/2020 |
FINLAY |
SOBERANA PEDIATRIA CLINICA 1 |
23/07/2021 |
FINLAY |
Stem cell assisted centrifugal fat transfer |
26/03/2021 |
HHA |
Stem cells in patients with lung lesions (COVID-19) |
03/07/2020 |
IHI |
Subcutaneous immunotherapy with PROLINEM-DS-Asthma- Adults-Fase II |
14/06/2018 |
BIOCEN |